Organization
Medical Sciences Division, University of Oxford, Headington, Oxford, United Kingdom
4 abstracts
Abstract
Efficacy and safety of triplet nivolumab, relatlimab, and ipilimumab (NIVO + RELA + IPI) in advanced melanoma: Results from RELATIVITY-048.Org: Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy, University Hospital Zurich, Zürich, Switzerland, CEPCM, Dermatology and Skin Cancer Department, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Marseille, France, Linear Clinical Research, Nedlands, Western Australia, Australia, Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD,
Abstract
Phase 1 safety and efficacy of IMC-F106C, a PRAME × CD3 ImmTAC bispecific, in post-checkpoint cutaneous melanoma (CM).Org: The Angeles Clinic and Research Institute, a Cedars-Sinai Affiliate, Los Angeles, CA, HCA Healthcare global Sarah Cannon Research Institute, London, United Kingdom, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom, University of Chicago, Comprehensive Cancer Center, Chicago, IL, Jefferson Medical College, Philadelphia, PA,
Abstract
A NOVEL MRI-BASED ANALYSIS WORKFLOW FOR SPINAL LESIONS IN ANKYLOSING SPONDYLITIS Org: Image Analysis Ltd, Research Services, Medical Sciences Division, University of Oxford, Headington, Oxford, United Kingdom, University of Oxford,
Abstract
A SYSTEMATIC ANALYSIS OF CIRCULATING B CELL POPULATIONS IN HEALTHY AND SLE SUBJECTSOrg: Clinical Immunology Unit, Dept. of Medicine, Department of Pathology, Rogaland Central Hospital, Stavanger, Norway, Amgen, Thousand Oaks, Cedars-Sinai Medical Center, Los Angeles Medical Center,